Estrogen Patches vs. Injections: Routes of Administration

Research-informed explainer — last updated April 11, 2026

Estrogen patches and injections both deliver estradiol — the same hormone — but they do it differently, and those differences matter for how your body responds. Patches release estradiol steadily through the skin, giving you relatively stable blood levels around the clock. Injections deliver a surge that peaks within a day or two and then falls off until the next dose. Neither is universally better; the right choice depends on your goals, your tolerance for fluctuating hormone levels, your bone health needs, and practical factors like how often you want to think about dosing.

This explainer draws on peer-reviewed research from three endocrinologists listed in the Convene directory. Danit Ariel, MD, at Stanford University School of Medicine published a 2023 review on how different hormone therapy formulations affect bone mineral density and fracture risk, with specific attention to transdermal delivery [1]. Brian Swiglo, M.D., at Abbott Northwestern Hospital co-authored a systematic review examining the effects of various estrogen preparations on bone health and a widely-cited Endocrine Society clinical practice guideline covering estrogen-progestin therapy [2][3]. Joanna Spencer-Segal, MD, at Michigan Medicine has published extensively on estrogen's effects throughout the brain, including how estradiol reaches and acts on neural tissue through multiple receptor pathways — work that is relevant to understanding why stable vs. fluctuating estradiol levels may have different effects beyond the reproductive system [4][5].

What estradiol actually does in the body

Estradiol is the primary form of estrogen in humans during the reproductive years. It binds to estrogen receptors found throughout the body — not just in reproductive organs, but in bone, brain, heart, skin, and liver. Those receptors come in two main types, alpha and beta, which are distributed differently across tissues and trigger different downstream effects.

Spencer-Segal's research on estrogen receptors in the hippocampus found that receptor activity in neural tissue varies depending on estradiol levels and how those levels fluctuate over time [4]. Her broader work on estrogen's effects in the brain documents that estradiol reaches tissues far beyond the hypothalamus, influencing mood, cognition, and neuroprotection through pathways that are sensitive to concentration changes [5]. That background matters when comparing routes of administration: a delivery method that produces wide swings in estradiol levels may not interact with these systems the same way a steady-state delivery does.

How the two routes deliver estradiol

Patches (transdermal estradiol) release the hormone through the skin at a controlled rate. You apply them to clean, dry skin — typically the lower abdomen, buttocks, or upper thigh — and change them once or twice a week depending on the product. Because absorption is continuous, blood levels stay relatively flat between changes. Transdermal delivery also bypasses the liver's first-pass metabolism, which means the estradiol that enters your bloodstream is the same bioidentical form as what the ovaries naturally produce.

Injections (typically injectable estradiol cypionate or estradiol valerate) deliver a large depot of the hormone that your body slowly absorbs from the injection site. Estradiol peaks within 24 to 72 hours of the injection, then declines until the next dose. Injection intervals are commonly every one to two weeks for estradiol cypionate and every one to four weeks for estradiol valerate. The practical consequence: your estradiol levels may be high at one point in the cycle and substantially lower at another, which some people notice in how they feel.

Both routes deliver bioidentical estradiol — not the synthetic conjugated equine estrogens used in some older oral formulations. This is worth noting because much of the early concern about hormone therapy risk (cardiovascular, clotting) came from studies of oral conjugated equine estrogens, not transdermal estradiol.

At a glance

Bone health: what the research shows

Bone protection is one of the most well-studied benefits of estrogen therapy, and it is relevant for anyone on long-term hormone therapy. Estrogens maintain bone mineral density by slowing the rate at which bone is broken down. When estrogen levels fall — whether from menopause, surgical removal of the ovaries, or other causes — bone loss accelerates.

Ariel's 2023 review in Current Opinion in Obstetrics & Gynecology examined evidence for different hormone therapy formulations and delivery routes in preventing low bone density [1]. The review found that transdermal estradiol performs well for preserving bone mineral density and reducing fracture risk, with bioidentical and transdermal formulations often clinically preferred over synthetic oral estrogens because of their improved safety profiles. The steady estradiol levels that transdermal delivery provides appear to translate into consistent bone-protective effects.

Swiglo's systematic review on estrogen preparations and bone health in premenopausal women examined multiple formulation types and found that the effects on bone are real but vary depending on how the estrogen is delivered [2]. The overall picture from this body of literature: transdermal estradiol has solid evidence for bone protection. Injectable estradiol has less published data specifically on bone endpoints, though the hormone itself is the same, and what evidence exists does not suggest it is inferior.

Estradiol level fluctuations and how they feel

One practical difference that does not always appear in clinical studies is how people feel across the dose cycle. With patches, most people experience stable mood, energy, and symptom control because their estradiol levels do not swing widely. With injections, some people report feeling better in the days after an injection (when estradiol is at its peak) and noticing a dip in energy or mood toward the end of the injection interval (when levels are lower).

This is not universal. Some people do well on a two-week injection schedule with no noticeable fluctuation in how they feel. Others switch to weekly injections specifically to reduce that cycle. There is no randomized trial that has directly compared quality of life across patch and injection schedules in this way, but the pharmacokinetics explain why the pattern occurs.

Clotting risk and oral estrogens: what the data is not saying

You may have read that estrogen increases the risk of blood clots (venous thromboembolism). That risk is real for oral estrogens, which undergo first-pass metabolism in the liver and increase production of clotting factors. The relationship is weaker for transdermal estradiol because it bypasses the liver. Injections, like patches, also bypass the liver. So the elevated clot risk seen in older hormone therapy trials does not apply the same way to either patches or injections — though individual risk factors (personal or family history of clots, prolonged immobility, certain genetic clotting disorders) always matter and should be discussed with your doctor.

Practical considerations

Patches are discreet and easy to use once you find placement that works for your body type. They can occasionally cause skin irritation at the application site, and they may not stay on well if you sweat heavily during exercise or swimming. Some people try different patch brands before finding one that adheres reliably.

Injections require learning to give yourself a subcutaneous (under the skin) or intramuscular shot, which some people find straightforward after a few tries and others prefer to avoid. Needles, syringes, and the medication itself are generally inexpensive and widely available by prescription. The ability to adjust the dose and interval gives some people more flexibility for fine-tuning their levels in coordination with their prescribing doctor.

Neither route requires refrigeration. Both require a prescription.

What your endocrinologist will want to monitor

Regardless of which route you use, your doctor will check estradiol blood levels periodically to confirm you are in the target range for your clinical goals. With patches, a single trough measurement (taken just before a patch change) is usually sufficient. With injections, some clinicians check both peak levels (a day or two after injection) and trough levels (just before the next injection) to understand the full range you are experiencing.

The Endocrine Society's clinical guideline on estrogen-progestin therapy, co-authored by Swiglo, outlines the monitoring framework that clinicians use when managing estrogen therapy and its downstream effects on hormone-sensitive systems [3]. That guideline structure — regular lab checks, attention to bone health over time, and assessment of cardiovascular risk factors — applies to anyone on ongoing estrogen therapy regardless of route.

Questions to ask your doctor

• What estradiol blood level range are you aiming for in my case, and how will we know if my current dose is hitting it?
• Given my lifestyle (exercise habits, skin sensitivity, comfort with injections), which route makes more practical sense?
• How often will my bone density be monitored, and at what point would you recommend a DEXA scan?
• If I start on one route and want to switch, how do we manage that transition without disrupting my hormone levels?
• What signs or symptoms should prompt me to call before my next scheduled appointment?

The bottom line

Patches and injections both deliver bioidentical estradiol that bypasses the liver — setting them apart from older oral formulations with a less favorable safety profile. Patches produce stable, steady blood levels and have strong evidence for bone protection. Injections produce a peak-and-trough pattern that some people tolerate well and others find affects their mood or energy across the cycle. The practical choice often comes down to preference: consistent low-maintenance dosing with patches versus flexibility and low cost with injections. Your endocrinologist can help you match the route to your specific hormone targets, bone health baseline, and day-to-day priorities.